Bg pattern

AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Azelastina MABO 0.5 mg/ml, Eye Drops Solution

Azelastina Hydrochloride 0.05% (0.5 mg/ml)

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Azelastina MABO and what is it used for
  2. What you need to know before starting to use Azelastina MABO
  3. How to use Azelastina MABO
  4. Possible side effects
  5. Storage of Azelastina MABO
  6. Package Contents and Additional Information

1. What is Azelastina MABO and what is it used for

Azelastina MABO contains azelastine, which belongs to a group of medications called antihistamines.

Antihistamines prevent the effects of substances like histamine that the body produces as part of an allergic reaction. Azelastine has been shown to reduce ocular inflammation.

Azelastina MABO is used for the treatment and prevention of ocular disorders caused by hay fever (seasonal allergic conjunctivitis) in adults and children from 4 years of age.

Azelastina MABO is also used for the treatment of ocular disorders caused by allergy to substances such as house dust mites or animal hair (perennial allergic conjunctivitis) in adults and children from 12 years of age.

Azelastina MABO is not suitable for the treatment of ocular infections.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Azelastina MABO

Do not use Azelastina MABO:

  • If you are allergic to azelastine hydrochloride or any of the other components of this medication (listed in section 6).

If this is the case, inform your doctor or pharmacist.

Warnings and Precautions

Consult your doctor or pharmacist before starting to use Azelastina MABO

  • If you are not sure that your ocular symptoms are caused by an allergy. In particular, if they only affect one eye; if your vision has worsened; or if you have eye pain and no nasal symptoms, it may be an infection rather than an allergy.
  • If your symptoms worsen or last more than 48 hours without notable improvement despite using Azelastina MABO.
  • You are taking other medications without a medical prescription.
  • You use contact lenses.

It is recommended not to use contact lenses until the signs and symptoms of allergic conjunctivitis have disappeared.

Using Azelastina MABO with other medications

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

It is unknown if Azelastina MABO may be affected by other medications.

Pregnancy, Breastfeeding, and Fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and Using Machines

You may notice blurred vision immediately after applying Azelastina MABO. Do not drive or use machines until this effect has disappeared.

Azelastina MABO contains Benzalkonium Chloride

This medication contains 0.75 mg of benzalkonium chloride in each bottle.

Benzalkonium chloride can be absorbed by soft contact lenses and may alter their color. Remove contact lenses before using this medication and wait 15 minutes before putting them back.

Benzalkonium chloride may cause eye irritation, especially if you have dry eye or other corneal diseases (the transparent layer of the front of the eye). Consult your doctor if you feel any unusual sensation, itching, or pain in the eye after using this medication.

3. How to use Azelastina MABO

Follow the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Important: if you are not sure what the correct dose is or how to use this medication, consult your doctor or pharmacist.

Ocular disorders caused by hay fever (seasonal allergic conjunctivitis)

  • Use in adults and children from 4 years of age.
  • The recommended dose is one drop in each eye, in the morning and at night.

If you anticipate exposure to pollen, you can administer the normal dose of Azelastina MABO as a preventive measure before going outside.

Ocular disorders caused by allergy (perennial allergic conjunctivitis)

  • Use in adults and children from 12 years of age.
  • The recommended dose is one drop in each eye, in the morning and at night.

If your symptoms are severe, your doctor may increase the dose to one drop in each eye up to four times a day.

If possible, you should use Azelastina MABO regularly until your symptoms have disappeared.

If you stop using Azelastina MABO, your symptoms will likely recur.

Remember:

  • Do not use Azelastina MABO for more than 6 weeks.
  • Azelastina MABO should only be applied to the eyes.

Instructions for the proper use of Azelastina MABO

To facilitate the application of the eye drops, it may be helpful to sit in front of a mirror the first few times, so you can see what you are doing.

  1. Wash your hands.
  2. Gently clean the area around your eyes to remove any moisture (Scheme 1).
  3. Remove the cap from the bottle and check that the dropper is clean.
  4. Gently pull your lower eyelid down (Scheme 2).
  5. Carefully place one drop in the middle of the lower eyelid (Scheme 3). Make sure the dropper does not touch the eye.
  6. Release your lower eyelid and gently press the inner corner of your eye against the bridge of your nose (Scheme 4). Keeping your finger pressing on the nose, blink slowly a few times to spread the drop across the entire surface of the eye.
  7. Wipe away any excess medication with a tissue.
  8. Repeat this procedure in the other eye.

Sequence of four steps showing the application of eye drops with a finger pulling down the lower eyelid

Scheme 1 Scheme 2 Scheme 3 Scheme 4

If you use more Azelastina MABO than you should

If you have administered too much Azelastina MABO to your eyes, you will likely not have any problems. Generally, overdosing does not produce side effects. However, if you have applied an excessive amount of product and are concerned about this, consult your doctor.

In case of accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount administered, or go to the Emergency Department of the nearest hospital.

If you forget to use Azelastina MABO

Use your eye drops as soon as you remember and administer the next dose at your usual time. Do not use a double dose to make up for missed doses.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medications, Azelastina MABO can cause side effects, although not everyone will experience them. Side effects are usually not serious.

These effects include:

  • Frequent (may affect up to 1 in 10 people): Mild irritation (itching, stinging, tearing) in the eyes after using Azelastina MABO. These effects should not last long.
  • Uncommon (may affect up to 1 in 100 people): Bitter taste in the mouth. This effect should disappear quickly, especially if you take a drink.
  • Very rare (may affect up to 1 in 10,000 people): Allergic reaction (rash and itching).

Reporting Side Effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Azelastina MABO

Keep this medication out of the sight and reach of children.

No special storage conditions are required.

Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.

Once opened:Do not use Azelastina MABO when the bottle has been opened for more than 4 weeks.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Azelastina MABO

  • The active ingredient is azelastine hydrochloride 0.05% (0.5 mg/ml). Each drop contains 0.015 mg of azelastine hydrochloride.
  • The other ingredients are benzalkonium chloride, disodium edetate, hypromellose (E-464), sorbitol liquid (crystallizable) (E-420i), sodium hydroxide (E-524) to adjust pH, and water for injectable preparations.

Appearance of the Product and Package Contents

Azelastina MABO is a colorless and transparent solution.

Azelastina MABO is presented in a plastic bottle with a dropper. One bottle contains 6 ml.

Marketing Authorization Holder

MABO-FARMA. S.A.

Vía de los Poblados 3,

Building 6, 28033, Madrid,

Spain.

Manufacturer

MEIJI PHARMA SPAIN, S.A.

Avenida de Madrid, 94,

28802, Alcalá de Henares (Madrid)

Spain

Date of the Last Revision of this Package Leaflet: June 2015

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION

Discuss questions about AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION?
AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION?
The active ingredient in AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION is azelastine. This information helps identify medicines with the same composition but different brand names.
How much does AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION cost in pharmacies?
The average pharmacy price for AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION is around 5.87 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION?
AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION is manufactured by Mabo Farma S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to AZELASTINE MABO 0.5 mg/ml EYE DROPS SOLUTION?
Other medicines with the same active substance (azelastine) include AFLUON 0.5 mg/ml EYE DROPS SOLUTION, AZELASTINE ABAMED 0.5 mg/ml EYE DROPS SOLUTION, AZELASTINE POS 0.5 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media